Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$724.87 - $909.04 $6,523 - $8,181
9 Added 2.96%
313 $283,000
Q1 2024

May 10, 2024

BUY
$592.2 - $792.28 $180,028 - $240,853
304 New
304 $236,000
Q2 2023

Aug 11, 2023

BUY
$350.74 - $468.98 $149,765 - $200,254
427 New
427 $200,000
Q4 2022

Feb 13, 2023

SELL
$321.55 - $374.67 $29,904 - $34,844
-93 Reduced 12.09%
676 $247,000
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $10,080 - $11,487
-34 Reduced 4.23%
769 $249,000
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $180,554 - $224,069
803 New
803 $222,000
Q1 2021

May 13, 2021

SELL
$164.32 - $212.72 $2.76 Million - $3.58 Million
-16,820 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$130.46 - $172.63 $56,358 - $74,576
432 Added 2.64%
16,820 $2.21 Million
Q3 2020

Nov 13, 2020

SELL
$146.22 - $169.13 $96,651 - $111,794
-661 Reduced 3.88%
16,388 $2.43 Million
Q2 2020

Aug 13, 2020

SELL
$136.42 - $164.18 $59,069 - $71,089
-433 Reduced 2.48%
17,049 $2.8 Million
Q1 2020

May 11, 2020

SELL
$119.05 - $147.35 $189,527 - $234,581
-1,592 Reduced 8.35%
17,482 $2.43 Million
Q4 2019

Feb 14, 2020

BUY
$106.92 - $132.43 $272,111 - $337,034
2,545 Added 15.4%
19,074 $2.51 Million
Q3 2019

Nov 14, 2019

BUY
$106.79 - $116.16 $1.77 Million - $1.92 Million
16,529 New
16,529 $1.85 Million
Q2 2019

Aug 14, 2019

SELL
$110.79 - $129.32 $181,030 - $211,308
-1,634 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$111.31 - $131.02 $358,863 - $422,408
-3,224 Reduced 66.36%
1,634 $212,000
Q4 2018

Feb 14, 2019

SELL
$105.9 - $118.64 $4.57 Million - $5.12 Million
-43,192 Reduced 89.89%
4,858 $562,000
Q3 2018

Nov 14, 2018

SELL
$85.86 - $107.31 $182,967 - $228,677
-2,131 Reduced 4.25%
48,050 $5.16 Million
Q2 2018

Aug 14, 2018

BUY
$75.7 - $86.88 $129,447 - $148,564
1,710 Added 3.53%
50,181 $4.28 Million
Q1 2018

May 15, 2018

BUY
$74.21 - $87.6 $303,147 - $357,846
4,085 Added 9.2%
48,471 $3.75 Million
Q4 2017

Feb 14, 2018

BUY
$81.94 - $87.89 $779,659 - $836,273
9,515 Added 27.29%
44,386 $3.75 Million
Q3 2017

Nov 14, 2017

BUY
$77.07 - $85.54 $2.69 Million - $2.98 Million
34,871
34,871 $2.98 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Cornercap Investment Counsel Inc Portfolio

Follow Cornercap Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornercap Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cornercap Investment Counsel Inc with notifications on news.